Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADK | P55263 | 1/20 | 0.44 |
| ▸ | ADORA3 | P0DMS8 | 6/20 | 0.42 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.42 |
| ▸ | METTL3 | Q86U44 | 1/20 | 0.42 |
| ▸ | METTL14 | Q9HCE5 | 1/20 | 0.42 |
| ▸ | PRMT5 | O14744 | 3/20 | 0.41 |
| ▸ | WDR77 | Q9BQA1 | 3/20 | 0.41 |
| ▸ | ADORA2A | P29274 | 5/20 | 0.40 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.40 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14154286 | 0.88 | ADK (0.44) | ADKADORA3SLC29A1METTL3METTL14 | |
| SCHEMBL14154308 | 0.88 | PRMT5 (0.48) | ADKADORA3METTL3METTL14PRMT5 | |
| SCHEMBL14154376 | 0.87 | ADK (0.43) | ADKADORA3SLC29A1METTL3METTL14 | |
| SCHEMBL14154333 | 0.83 | PRMT5 (0.51) | ADKADORA3METTL3METTL14PRMT5 | |
| SCHEMBL14154288 | 0.82 | ADK (0.51) | ADK | |
| SCHEMBL14154369 | 0.81 | ADK (0.52) | ADKMETTL3PRMT5WDR77ADORA2A | |
| SCHEMBL16480592 | 0.81 | ADK (0.52) | ADKMETTL3PRMT5WDR77ADORA2A | |
| SCHEMBL14111524 | 0.80 | ADORA3 (0.38) | ADKADORA3SLC29A1ADORA2AADORA1 | |
| SCHEMBL14378917 | 0.80 | ADK (0.39) | ADKADORA3SLC29A1METTL3METTL14 | |
| SCHEMBL13020659 | 0.80 | ADK (0.39) | ADKADORA3SLC29A1METTL3METTL14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7405204-B2 | Nucleoside compounds for treating viral infections | GENELABS TECHNOLOGIES, INC. (US) | 2008-07-29 | — | — | US | disclosed |